We used quantitative qRT-PCR to measure FGFRL1 mRNA expression in tissue samples of primary PCa (n = 48) and adjacent non-malignant prostate (AdjPr) available from 36 RPs of the patients. The gene discussed is FGFRL1; the disease is posterior cortical atrophy.